The treatment, known as extended aldosterone synthase inhibition (EASI), involves taking a new class of drugs for 6–12 months to target excess production of the hormone aldosterone, a common cause of high blood pressure. Unlike conventional treatments that control blood pressure, the EASI treatment appears to reverse its underlying cause, removing the need for lifelong medication. Until now, cure has required surgery to remove an entire adrenal gland.
The study, published in the New England Journal of Medicine, followed 14 people treated at eight centers across the United States. Researchers found that the EASI treatment led to sustained reversal of excess aldosterone production and partial or complete resolution of high blood pressure for up to two years after treatment ended.